{"id":68894,"date":"2024-06-13T09:33:01","date_gmt":"2024-06-13T14:33:01","guid":{"rendered":"https:\/\/www.partnershipagainstcancer.ca\/topics\/breast-indicators-2018-2021\/key-statistics\/"},"modified":"2024-06-13T11:47:54","modified_gmt":"2024-06-13T16:47:54","slug":"key-statistics","status":"publish","type":"topics","link":"https:\/\/www.partnershipagainstcancer.ca\/fr\/topics\/breast-indicators-2018-2021\/key-statistics\/","title":{"rendered":"Statistiques cl\u00e9s sur le d\u00e9pistage du cancer du sein au Canada"},"content":{"rendered":"<h2>Le fardeau du cancer du sein chez les femmes au Canada (2023)<\/h2>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"aligncenter size-full wp-image-69229\" src=\"https:\/\/www.partnershipagainstcancer.ca\/wp-content\/uploads\/2023\/12\/Burden-breast-cancer-FR.png\" alt=\"Chez les femmes au Canada, le cancer du sein est le cancer le plus souvent diagnostiqu\u00e9 et la deuxi\u00e8me cause de d\u00e9c\u00e8s par cancer. On estime qu\u2019en\u202f2023, 80\u202ffemmes recevront un diagnostic de cancer du sein chaque jour (29\u202f400 au total) et\u202f15\u202ffemmes mourront chaque jour d\u2019un cancer du sein (5\u202f400 au total). La probabilit\u00e9 \u00e0 vie de contracter un cancer du sein est de 13\u202f% chez les femmes. La probabilit\u00e9 \u00e0 vie de mourir d\u2019un cancer du sein est de\u202f2,8\u202f%.\" width=\"2543\" height=\"3300\" srcset=\"https:\/\/www.partnershipagainstcancer.ca\/wp-content\/uploads\/2023\/12\/Burden-breast-cancer-FR.png 2543w, https:\/\/www.partnershipagainstcancer.ca\/wp-content\/uploads\/2023\/12\/Burden-breast-cancer-FR-231x300.png 231w, https:\/\/www.partnershipagainstcancer.ca\/wp-content\/uploads\/2023\/12\/Burden-breast-cancer-FR-789x1024.png 789w, https:\/\/www.partnershipagainstcancer.ca\/wp-content\/uploads\/2023\/12\/Burden-breast-cancer-FR-768x997.png 768w, https:\/\/www.partnershipagainstcancer.ca\/wp-content\/uploads\/2023\/12\/Burden-breast-cancer-FR-1184x1536.png 1184w, https:\/\/www.partnershipagainstcancer.ca\/wp-content\/uploads\/2023\/12\/Burden-breast-cancer-FR-1578x2048.png 1578w\" sizes=\"auto, (max-width: 2543px) 100vw, 2543px\" \/><br \/>\n<sub><a href=\"https:\/\/www.partnershipagainstcancer.ca\/fr\/data-tables-breast-indicators\/\">Description textuelle et notes de bas de page <\/a><\/sub><\/p>\n<p>Plusieurs essais contr\u00f4l\u00e9s randomis\u00e9s (ECR) ont d\u00e9montr\u00e9 l\u2019avantage du d\u00e9pistage syst\u00e9matique du cancer du sein par mammographie pour r\u00e9duire la mortalit\u00e9 due \u00e0 cette maladie<sup>1<\/sup>. Une m\u00e9ta-analyse de ces ECR a rapport\u00e9 une r\u00e9duction d\u2019environ\u202f20\u202f % de la mortalit\u00e9 par cancer du sein attribuable au d\u00e9pistage r\u00e9gulier par mammographie chez les femmes invit\u00e9es \u00e0 un d\u00e9pistage. Une \u00e9tude pancanadienne sur les programmes de d\u00e9pistage organis\u00e9 du cancer du sein a \u00e9galement r\u00e9v\u00e9l\u00e9 que la mortalit\u00e9 par cancer du sein \u00e9tait\u202f40\u202f% inf\u00e9rieure \u00e0 celle attendue chez les femmes ayant particip\u00e9 \u00e0 des programmes de d\u00e9pistage du cancer du sein par rapport \u00e0 celles n\u2019y ayant pas particip\u00e9<sup>2<\/sup>.<br \/>\n<a name=\"incidence-mortality\"><\/a><\/p>\n<h3>Taux d\u2019incidence et de mortalit\u00e9 normalis\u00e9s selon l\u2019\u00e2ge pour le cancer du sein (femmes), Canada, 1990 \u00e0\u202f2022<\/h3>\n<p><link rel='stylesheet' href='https:\/\/cdnjs.cloudflare.com\/ajax\/libs\/font-awesome\/4.7.0\/css\/font-awesome.min.css'><link rel='stylesheet' href='https:\/\/www.partnershipagainstcancer.ca\/wp-content\/plugins\/cpac-toolbox\/cpac-toolbox.css?v2'><script type='text\/javascript' src='https:\/\/www.partnershipagainstcancer.ca\/wp-content\/plugins\/cpac-toolbox\/cpac-toolbox.js?v2'><\/script><style>\niframe.cpac-dashboard { .statusBar{display:none;}\r\npbi-status-bar{opacity:0.1;background: white;height: 0;}\r\n.backgroundContainer.outspaceContainer{background:#fff!important;} }\n<\/style><div class='cpac-dashboard-container'><iframe allowfullscreen='allowfullscreen' title='cpac-dashboard-eyJrIjoiMmU2MmQ0ZGItYjZhNC00YTI1LWI0ZWMtNzYwZmY3MWU2ZWMxIiwidCI6ImQxODkwM2ZiLTk2OTMtNDMyZC1iMDA0LTI3M2I3MDE1NDQ5MCJ9_792' id='dashboard-eyJrIjoiMmU2MmQ0ZGItYjZhNC00YTI1LWI0ZWMtNzYwZmY3MWU2ZWMxIiwidCI6ImQxODkwM2ZiLTk2OTMtNDMyZC1iMDA0LTI3M2I3MDE1NDQ5MCJ9_792' src='https:\/\/dashboard.cpacc.ca\/report\/eyJrIjoiMmU2MmQ0ZGItYjZhNC00YTI1LWI0ZWMtNzYwZmY3MWU2ZWMxIiwidCI6ImQxODkwM2ZiLTk2OTMtNDMyZC1iMDA0LTI3M2I3MDE1NDQ5MCJ9&language=fr-CA' class='cpac-dashboard'  style='width:100%'><\/iframe><\/div><script>\n                    var is_fullreport = 0;\n                    var scrolled = false;\n                    window.addEventListener('message', function(e){\n                            var this_frame = document.getElementById('dashboard-eyJrIjoiMmU2MmQ0ZGItYjZhNC00YTI1LWI0ZWMtNzYwZmY3MWU2ZWMxIiwidCI6ImQxODkwM2ZiLTk2OTMtNDMyZC1iMDA0LTI3M2I3MDE1NDQ5MCJ9_792');\n\n\t\t\t            \/\/ Extract token from parent src\n    \t\t\t        var parentToken = this_frame.src.split('\/').pop();\n\t\t\t\tparentToken = parentToken.split('&')[0];\n\n\/\/                            console.log(JSON.stringify(e.data));\n                    \tif (e.data && e.data.hasOwnProperty('cpac_height') && \n                            e.data.hasOwnProperty('iframe_token') && \n                            e.data.iframe_token === parentToken && \n                            e.origin == 'https:\/\/dashboard.cpacc.ca') { \n                            \n                            console.log('cpac-dashboard: resizing iframe height to ' + e.data.cpac_height + ' for id=dashboard-eyJrIjoiMmU2MmQ0ZGItYjZhNC00YTI1LWI0ZWMtNzYwZmY3MWU2ZWMxIiwidCI6ImQxODkwM2ZiLTk2OTMtNDMyZC1iMDA0LTI3M2I3MDE1NDQ5MCJ9_792[' + e.origin + ']' );\n\/\/                                this_frame.height = e.data.cpac_height + 'px';\n                            \n                            if(is_fullreport){\n                                this_frame.style.height = e.data.cpac_height + 'px';\n                            }else if(e.data.cpac_height>200 && e.data.cpac_height<1000){\n                                \/\/ if height = 401px then style.height = 410px\n                                \/\/ if height = 373px then style.height = 380px\n                                \/\/ if height = 350px then style.height = 350px\n                                const cpac_height = (parseInt(e.data.cpac_height\/10)+((e.data.cpac_height%10>0)?1:0))*10;\n                                this_frame.style.height = cpac_height + 'px';\n                            }else{\n                                this_frame.style.height = '500px';\n                            }\n                        }\n\n                            if (e.data && e.data.hasOwnProperty('target_element_y') && e.origin == 'https:\/\/dashboard.cpacc.ca' && !scrolled) {\n                                console.log('received element >>>'+e.data.target_element_y);\n                                let targetYFromDoc = 0;\n                                let element = document.getElementById('dashboard-eyJrIjoiMmU2MmQ0ZGItYjZhNC00YTI1LWI0ZWMtNzYwZmY3MWU2ZWMxIiwidCI6ImQxODkwM2ZiLTk2OTMtNDMyZC1iMDA0LTI3M2I3MDE1NDQ5MCJ9_792');\n                                while(element){\n                                    targetYFromDoc += parseInt(element.offsetTop - element.scrollTop + element.clientTop);\n                                    element = element.offsetParent;\n                                }\n                                targetYFromDoc += parseInt(e.data.target_element_y?e.data.target_element_y:0);\n                                window.scrollTo({top: targetYFromDoc, behavior: 'smooth'});\n                                scrolled = true;\n                            }\n                        });\n                        var frame_eyJrIjoiMmU2MmQ0ZGItYjZhNC00YTI1LWI0ZWMtNzYwZmY3MWU2ZWMxIiwidCI6ImQxODkwM2ZiLTk2OTMtNDMyZC1iMDA0LTI3M2I3MDE1NDQ5MCJ9_792 = document.getElementById('dashboard-eyJrIjoiMmU2MmQ0ZGItYjZhNC00YTI1LWI0ZWMtNzYwZmY3MWU2ZWMxIiwidCI6ImQxODkwM2ZiLTk2OTMtNDMyZC1iMDA0LTI3M2I3MDE1NDQ5MCJ9_792');\n                        frame_eyJrIjoiMmU2MmQ0ZGItYjZhNC00YTI1LWI0ZWMtNzYwZmY3MWU2ZWMxIiwidCI6ImQxODkwM2ZiLTk2OTMtNDMyZC1iMDA0LTI3M2I3MDE1NDQ5MCJ9_792.onload = function() {\n                            const styleCode = '.statusBar{display:none;}pbi-status-bar{opacity:0.1;background:white;height:0;}.backgroundContainer.outspaceContainer{background:#fff!important;}';\n                            frame_eyJrIjoiMmU2MmQ0ZGItYjZhNC00YTI1LWI0ZWMtNzYwZmY3MWU2ZWMxIiwidCI6ImQxODkwM2ZiLTk2OTMtNDMyZC1iMDA0LTI3M2I3MDE1NDQ5MCJ9_792.contentWindow.postMessage({'style':styleCode ,'value':'sendStyle'},'*');\n                            const targetId = 'null';\n                            frame_eyJrIjoiMmU2MmQ0ZGItYjZhNC00YTI1LWI0ZWMtNzYwZmY3MWU2ZWMxIiwidCI6ImQxODkwM2ZiLTk2OTMtNDMyZC1iMDA0LTI3M2I3MDE1NDQ5MCJ9_792.contentWindow.postMessage({'targetId':targetId,'value':'requestTargetPosition'},'*');\n                            const selectBoxId = 'null';\n                            const selectBoxValue = '1';\n                            frame_eyJrIjoiMmU2MmQ0ZGItYjZhNC00YTI1LWI0ZWMtNzYwZmY3MWU2ZWMxIiwidCI6ImQxODkwM2ZiLTk2OTMtNDMyZC1iMDA0LTI3M2I3MDE1NDQ5MCJ9_792.contentWindow.postMessage({'selectBoxId':selectBoxId,'selectBoxValue':selectBoxValue,'value':'requestTargetSelectBoxTrigger'},'*');\n                        };\n                    <\/script><br \/>\n<a style=\"margin-top: 50px; display: block;\" href=\"https:\/\/www.partnershipagainstcancer.ca\/fr\/data-tables-breast-indicators\/#incidence-mortality\"><sub>Tableau de donn\u00e9es et note de bas de page <\/sub><\/a><\/p>\n<p>Au Canada, <strong>l\u2019incidence normalis\u00e9e selon l\u2019\u00e2ge du cancer du sein<\/strong> a l\u00e9g\u00e8rement augment\u00e9 entre\u202f1980 et le d\u00e9but des ann\u00e9es\u202f1990. Cette augmentation a \u00e9t\u00e9 en partie attribu\u00e9e au recours accru aux mammographies de d\u00e9pistage opportunistes, avant la mise en \u0153uvre de programmes de d\u00e9pistage organis\u00e9, et aux changements \u00e0 long terme des facteurs hormonaux, tels que l\u2019utilisation de contraceptifs oraux et l\u2019ob\u00e9sit\u00e9, dont on a d\u00e9termin\u00e9 qu\u2019ils augmentaient le risque de cancer du sein<sup>3<\/sup>. Depuis\u202f1991, les taux d\u2019incidence du cancer du sein sont rest\u00e9s relativement stables, avec des pics autour de\u202f1999 et\u202f2011, \u00e0 respectivement\u202f136,5\u202fcas pour\u202f100\u202f000\u202ffemmes et\u202f131,5\u202fcas pour\u202f100\u202f000\u202ffemmes.<\/p>\n<p>Le <strong>taux de mortalit\u00e9 par cancer du sein normalis\u00e9 selon l\u2019\u00e2ge<\/strong> est en baisse constante, passant de\u202f41,6 \u00e0\u202f22,4\u202fd\u00e9c\u00e8s pour\u202f100\u202f000\u202fcas entre\u202f1990 et\u202f2022. Cette baisse a \u00e9t\u00e9 attribu\u00e9e \u00e0 des facteurs tels que l\u2019augmentation du d\u00e9pistage par mammographie et l\u2019am\u00e9lioration du traitement du cancer du sein<sup>3<\/sup>.<\/p>\n<h2>Situation actuelle du d\u00e9pistage du cancer du sein au Canada<\/h2>\n<p>Un d\u00e9pistage organis\u00e9 du cancer du sein a \u00e9t\u00e9 mis en place dans <strong>l\u2019ensemble des provinces et territoires du Canada, \u00e0 l\u2019exception du Nunavut qui offre un d\u00e9pistage opportuniste<\/strong>. La plupart des provinces et des territoires recommandent un d\u00e9pistage par mammographie chez les personnes asymptomatiques pr\u00e9sentant un risque moyen, tous les deux ans, \u00e0 partir de l\u2019\u00e2ge de\u202f50\u202fans, jusqu\u2019\u00e0\u202f74 ou\u202f75\u202fans. Tous les territoires de comp\u00e9tence figurant dans ce rapport avaient recours \u00e0 la mammographie\u202f2D comme principal outil de d\u00e9pistage, \u00e0 l\u2019exception de l\u2019Alberta qui utilisait aussi bien la mammographie\u202f2D que la mammographie\u202f3D. Le recours \u00e0 d\u2019autres modalit\u00e9s que la mammographie peut d\u00e9pendre du degr\u00e9 de risque que pr\u00e9sente la personne.<\/p>\n<p>Des renseignements suppl\u00e9mentaires sur le d\u00e9pistage du cancer du sein au Canada et sur les lignes directrices s\u2019appliquant dans chaque territoire de comp\u00e9tence sont disponibles dans l\u2019analyse de l\u2019environnement <a href=\"https:\/\/www.partnershipagainstcancer.ca\/fr\/topics\/breast-cancer-screening-in-canada-2021-2022\/summary\/\">D\u00e9pistage du cancer du sein au Canada\u202f: 2021-2022<\/a>. Dans un contexte o\u00f9 l\u2019environnement \u00e9volue rapidement, veuillez consulter votre programme local de d\u00e9pistage du cancer du sein pour obtenir les renseignements les plus r\u00e9cents.<\/p>\n<div style=\"height: 40px; width: 100%;\"><\/div>\n<style>.cpac-dashboard-container {margin-bottom: -60px;}<\/style>\n","protected":false},"excerpt":{"rendered":"<p>Le fardeau du cancer du sein chez les femmes au Canada (2023) Description textuelle et notes de bas de page Plusieurs essais contr\u00f4l\u00e9s randomis\u00e9s (ECR) ont d\u00e9montr\u00e9 l\u2019avantage du d\u00e9pistage syst\u00e9matique du cancer du sein par mammographie pour r\u00e9duire la mortalit\u00e9 due \u00e0 cette maladie1. Une m\u00e9ta-analyse de ces ECR a rapport\u00e9 une r\u00e9duction d\u2019environ\u202f20\u202f [&hellip;]<\/p>\n","protected":false},"author":24,"featured_media":0,"parent":68573,"menu_order":1,"template":"","topics_tags":[],"type-of-care":[],"cancer-continuum":[],"cancer-system-measurement":[],"dbt-cancer-site":[],"dbt-risk-factors":[],"dbt-population-characteristics":[],"class_list":["post-68894","topics","type-topics","status-publish","hentry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Canadian Partnership Against Cancer<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.partnershipagainstcancer.ca\/fr\/topics\/breast-indicators-2018-2021\/key-statistics\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Statistiques cl\u00e9s sur le d\u00e9pistage du cancer du sein au Canada - Canadian Partnership Against Cancer\" \/>\n<meta property=\"og:description\" content=\"Le fardeau du cancer du sein chez les femmes au Canada (2023) Description textuelle et notes de bas de page Plusieurs essais contr\u00f4l\u00e9s randomis\u00e9s (ECR) ont d\u00e9montr\u00e9 l\u2019avantage du d\u00e9pistage syst\u00e9matique du cancer du sein par mammographie pour r\u00e9duire la mortalit\u00e9 due \u00e0 cette maladie1. Une m\u00e9ta-analyse de ces ECR a rapport\u00e9 une r\u00e9duction d\u2019environ\u202f20\u202f [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.partnershipagainstcancer.ca\/fr\/topics\/breast-indicators-2018-2021\/key-statistics\/\" \/>\n<meta property=\"og:site_name\" content=\"Canadian Partnership Against Cancer\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/CanadianPartnershipAgainstCancer\/\" \/>\n<meta property=\"article:modified_time\" content=\"2024-06-13T16:47:54+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.partnershipagainstcancer.ca\/wp-content\/uploads\/2023\/12\/Burden-breast-cancer-FR.png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@cancerstratca\" \/>\n<meta name=\"twitter:label1\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data1\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.partnershipagainstcancer.ca\\\/fr\\\/topics\\\/breast-indicators-2018-2021\\\/key-statistics\\\/\",\"url\":\"https:\\\/\\\/www.partnershipagainstcancer.ca\\\/fr\\\/topics\\\/breast-indicators-2018-2021\\\/key-statistics\\\/\",\"name\":\"Statistiques cl\u00e9s sur le d\u00e9pistage du cancer du sein au Canada - Canadian Partnership Against Cancer\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/dev.partnershipagainstcancer.ca\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.partnershipagainstcancer.ca\\\/fr\\\/topics\\\/breast-indicators-2018-2021\\\/key-statistics\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.partnershipagainstcancer.ca\\\/fr\\\/topics\\\/breast-indicators-2018-2021\\\/key-statistics\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.partnershipagainstcancer.ca\\\/wp-content\\\/uploads\\\/2023\\\/12\\\/Burden-breast-cancer-FR.png\",\"datePublished\":\"2024-06-13T14:33:01+00:00\",\"dateModified\":\"2024-06-13T16:47:54+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.partnershipagainstcancer.ca\\\/fr\\\/topics\\\/breast-indicators-2018-2021\\\/key-statistics\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.partnershipagainstcancer.ca\\\/fr\\\/topics\\\/breast-indicators-2018-2021\\\/key-statistics\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/www.partnershipagainstcancer.ca\\\/fr\\\/topics\\\/breast-indicators-2018-2021\\\/key-statistics\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.partnershipagainstcancer.ca\\\/wp-content\\\/uploads\\\/2023\\\/12\\\/Burden-breast-cancer-FR.png\",\"contentUrl\":\"https:\\\/\\\/www.partnershipagainstcancer.ca\\\/wp-content\\\/uploads\\\/2023\\\/12\\\/Burden-breast-cancer-FR.png\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.partnershipagainstcancer.ca\\\/fr\\\/topics\\\/breast-indicators-2018-2021\\\/key-statistics\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Topics\",\"item\":\"https:\\\/\\\/www.partnershipagainstcancer.ca\\\/topics\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Surveillance et \u00e9valuation des indicateurs de la qualit\u00e9 du d\u00e9pistage du cancer du sein\",\"item\":\"https:\\\/\\\/www.partnershipagainstcancer.ca\\\/fr\\\/topics\\\/breast-indicators-2018-2021\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Statistiques cl\u00e9s sur le d\u00e9pistage du cancer du sein au Canada\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/dev.partnershipagainstcancer.ca\\\/#website\",\"url\":\"https:\\\/\\\/dev.partnershipagainstcancer.ca\\\/\",\"name\":\"Canadian Partnership Against Cancer\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/dev.partnershipagainstcancer.ca\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Canadian Partnership Against Cancer","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.partnershipagainstcancer.ca\/fr\/topics\/breast-indicators-2018-2021\/key-statistics\/","og_locale":"fr_FR","og_type":"article","og_title":"Statistiques cl\u00e9s sur le d\u00e9pistage du cancer du sein au Canada - Canadian Partnership Against Cancer","og_description":"Le fardeau du cancer du sein chez les femmes au Canada (2023) Description textuelle et notes de bas de page Plusieurs essais contr\u00f4l\u00e9s randomis\u00e9s (ECR) ont d\u00e9montr\u00e9 l\u2019avantage du d\u00e9pistage syst\u00e9matique du cancer du sein par mammographie pour r\u00e9duire la mortalit\u00e9 due \u00e0 cette maladie1. Une m\u00e9ta-analyse de ces ECR a rapport\u00e9 une r\u00e9duction d\u2019environ\u202f20\u202f [&hellip;]","og_url":"https:\/\/www.partnershipagainstcancer.ca\/fr\/topics\/breast-indicators-2018-2021\/key-statistics\/","og_site_name":"Canadian Partnership Against Cancer","article_publisher":"https:\/\/www.facebook.com\/CanadianPartnershipAgainstCancer\/","article_modified_time":"2024-06-13T16:47:54+00:00","og_image":[{"url":"https:\/\/www.partnershipagainstcancer.ca\/wp-content\/uploads\/2023\/12\/Burden-breast-cancer-FR.png","type":"","width":"","height":""}],"twitter_card":"summary_large_image","twitter_site":"@cancerstratca","twitter_misc":{"Dur\u00e9e de lecture estim\u00e9e":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.partnershipagainstcancer.ca\/fr\/topics\/breast-indicators-2018-2021\/key-statistics\/","url":"https:\/\/www.partnershipagainstcancer.ca\/fr\/topics\/breast-indicators-2018-2021\/key-statistics\/","name":"Statistiques cl\u00e9s sur le d\u00e9pistage du cancer du sein au Canada - Canadian Partnership Against Cancer","isPartOf":{"@id":"https:\/\/dev.partnershipagainstcancer.ca\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.partnershipagainstcancer.ca\/fr\/topics\/breast-indicators-2018-2021\/key-statistics\/#primaryimage"},"image":{"@id":"https:\/\/www.partnershipagainstcancer.ca\/fr\/topics\/breast-indicators-2018-2021\/key-statistics\/#primaryimage"},"thumbnailUrl":"https:\/\/www.partnershipagainstcancer.ca\/wp-content\/uploads\/2023\/12\/Burden-breast-cancer-FR.png","datePublished":"2024-06-13T14:33:01+00:00","dateModified":"2024-06-13T16:47:54+00:00","breadcrumb":{"@id":"https:\/\/www.partnershipagainstcancer.ca\/fr\/topics\/breast-indicators-2018-2021\/key-statistics\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.partnershipagainstcancer.ca\/fr\/topics\/breast-indicators-2018-2021\/key-statistics\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.partnershipagainstcancer.ca\/fr\/topics\/breast-indicators-2018-2021\/key-statistics\/#primaryimage","url":"https:\/\/www.partnershipagainstcancer.ca\/wp-content\/uploads\/2023\/12\/Burden-breast-cancer-FR.png","contentUrl":"https:\/\/www.partnershipagainstcancer.ca\/wp-content\/uploads\/2023\/12\/Burden-breast-cancer-FR.png"},{"@type":"BreadcrumbList","@id":"https:\/\/www.partnershipagainstcancer.ca\/fr\/topics\/breast-indicators-2018-2021\/key-statistics\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Topics","item":"https:\/\/www.partnershipagainstcancer.ca\/topics\/"},{"@type":"ListItem","position":2,"name":"Surveillance et \u00e9valuation des indicateurs de la qualit\u00e9 du d\u00e9pistage du cancer du sein","item":"https:\/\/www.partnershipagainstcancer.ca\/fr\/topics\/breast-indicators-2018-2021\/"},{"@type":"ListItem","position":3,"name":"Statistiques cl\u00e9s sur le d\u00e9pistage du cancer du sein au Canada"}]},{"@type":"WebSite","@id":"https:\/\/dev.partnershipagainstcancer.ca\/#website","url":"https:\/\/dev.partnershipagainstcancer.ca\/","name":"Canadian Partnership Against Cancer","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/dev.partnershipagainstcancer.ca\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"}]}},"_links":{"self":[{"href":"https:\/\/www.partnershipagainstcancer.ca\/fr\/wp-json\/wp\/v2\/topics\/68894","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.partnershipagainstcancer.ca\/fr\/wp-json\/wp\/v2\/topics"}],"about":[{"href":"https:\/\/www.partnershipagainstcancer.ca\/fr\/wp-json\/wp\/v2\/types\/topics"}],"author":[{"embeddable":true,"href":"https:\/\/www.partnershipagainstcancer.ca\/fr\/wp-json\/wp\/v2\/users\/24"}],"up":[{"embeddable":true,"href":"https:\/\/www.partnershipagainstcancer.ca\/fr\/wp-json\/wp\/v2\/topics\/68573"}],"wp:attachment":[{"href":"https:\/\/www.partnershipagainstcancer.ca\/fr\/wp-json\/wp\/v2\/media?parent=68894"}],"wp:term":[{"taxonomy":"topics_tags","embeddable":true,"href":"https:\/\/www.partnershipagainstcancer.ca\/fr\/wp-json\/wp\/v2\/topics_tags?post=68894"},{"taxonomy":"type-of-care","embeddable":true,"href":"https:\/\/www.partnershipagainstcancer.ca\/fr\/wp-json\/wp\/v2\/type-of-care?post=68894"},{"taxonomy":"cancer-continuum","embeddable":true,"href":"https:\/\/www.partnershipagainstcancer.ca\/fr\/wp-json\/wp\/v2\/cancer-continuum?post=68894"},{"taxonomy":"cancer-system-measurement","embeddable":true,"href":"https:\/\/www.partnershipagainstcancer.ca\/fr\/wp-json\/wp\/v2\/cancer-system-measurement?post=68894"},{"taxonomy":"dbt-cancer-site","embeddable":true,"href":"https:\/\/www.partnershipagainstcancer.ca\/fr\/wp-json\/wp\/v2\/dbt-cancer-site?post=68894"},{"taxonomy":"dbt-risk-factors","embeddable":true,"href":"https:\/\/www.partnershipagainstcancer.ca\/fr\/wp-json\/wp\/v2\/dbt-risk-factors?post=68894"},{"taxonomy":"dbt-population-characteristics","embeddable":true,"href":"https:\/\/www.partnershipagainstcancer.ca\/fr\/wp-json\/wp\/v2\/dbt-population-characteristics?post=68894"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}